R Hovland

Author PubWeight™ 9.71^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.	Cell Death Differ	1999	1.06
2	Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.	Leukemia	2013	1.00
3	Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.	Oncogene	2011	0.96
4	Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels.	Leukemia	2007	0.94
5	A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients.	Neuropathol Appl Neurobiol	2011	0.92
6	Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia.	Blood Cancer J	2011	0.87
7	PHF6 Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females.	Mol Syndromol	2011	0.82
8	Tiling resolution array CGH of dic(7;9)(p11 approximately 13;p11 approximately 13) in B-cell precursor acute lymphoblastic leukemia reveals clustered breakpoints at 7p11.2 approximately 12.1 and 9p13.1.	Cytogenet Genome Res	2007	0.81
9	Loss-of-Function CNKSR2 Mutation Is a Likely Cause of Non-Syndromic X-Linked Intellectual Disability.	Mol Syndromol	2011	0.80
10	Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients.	Cell Prolif	2013	0.79
11	The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status.	Leukemia	2011	0.78
12	[Nightmare for the health system].	Tidsskr Sykepl	1998	0.75